Q&A: The economic forces that drive prescription drug prices
Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.
Oct 31, 2025
0
0
Nucleic Acids, Nucleotides, and Nucleosides: News and Research on Sofosbuvir
MeSH tree: D13.695.827.919.877.500
Mutating hepatitis viruses make drug treatment difficult: Study highlights importance of variant profiling
Hepatitis E affects over 20 million people worldwide. It clears up without any consequences in most cases, but it can pose a risk to pregnant women and immunocompromised patients. There are no specific active substances against ...
Jan 23, 2024
0
0
Single hepatitis E mutation renders sofosbuvir therapy ineffective
So far, there are no specific drugs to treat the hepatitis E virus. Doctors only have the broad-spectrum antiviral drug ribavirin at their disposal, which is often associated with severe side effects. Drugs against other ...
Jun 21, 2023
0
1
The push to eliminate hepatitis C
Why does the White House want to put $11.3 billion toward eliminating hepatitis C? Because as many as 75% of people who have it don't know it.
May 17, 2023
0
7
Organoids reveal how SARS-CoV-2 damages brain cells—and a potential treatment
Using human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus that causes COVID-19 ...
Nov 3, 2022
0
70
As hepatitis C proliferates, states lift barriers to treatment
While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there's a bright spot: Some states are now making it easier for patients ...
Oct 20, 2022
0
19
